KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | 0.0% | 18,857 | +7.1% | 0.00% | 0.0% |
| Q3 2021 | $102,000 | -94.6% | 17,613 | -90.1% | 0.00% | -95.7% |
| Q1 2021 | $1,880,000 | +132.1% | 178,704 | +318.7% | 0.02% | +109.1% |
| Q2 2020 | $810,000 | +180.3% | 42,680 | +183.9% | 0.01% | -38.9% |
| Q1 2020 | $289,000 | -82.7% | 15,036 | -82.7% | 0.02% | -56.1% |
| Q4 2019 | $1,669,000 | -39.1% | 87,067 | -69.5% | 0.04% | -48.8% |
| Q3 2019 | $2,742,000 | +348.0% | 285,100 | +172.0% | 0.08% | +281.0% |
| Q1 2019 | $612,000 | -46.8% | 104,800 | -14.7% | 0.02% | -52.3% |
| Q4 2018 | $1,151,000 | -83.8% | 122,800 | -70.6% | 0.04% | -86.1% |
| Q3 2018 | $7,121,000 | +0.8% | 418,100 | +0.6% | 0.32% | -17.2% |
| Q2 2018 | $7,061,000 | +44.1% | 415,600 | +0.7% | 0.38% | +4.4% |
| Q1 2018 | $4,900,000 | +104.2% | 412,892 | +65.2% | 0.37% | +86.3% |
| Q4 2017 | $2,400,000 | -12.6% | 250,000 | 0.0% | 0.20% | -21.5% |
| Q3 2017 | $2,745,000 | -6.7% | 250,000 | -23.1% | 0.25% | -17.2% |
| Q2 2017 | $2,941,000 | -32.6% | 325,000 | -4.4% | 0.30% | -30.8% |
| Q1 2017 | $4,366,000 | – | 340,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |